BARX2 and gastric cancer: Barx2 was greatly reduced in the majority of GC tumor tissues with strong staining in only 17/264 (6.4%) specimens (Figure 2b, 2f), weak staining in 82/264 (31.1%) specimens (Figure 2c, 2g), and negative staining in 165/264 (62.5%) specimens (Figure 2d, 2h).